lansoprazole has been researched along with Cronkhite-Canada Syndrome in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Cronkhite-Canada Syndrome: A nonfamilial polyposis syndrome that is characterized by the presence of diffuse gastrointestinal polyposis, DIARRHEA, and PROTEIN-LOSING ENTEROPATHY. It was first reported by Cronkhite and Canada in 1955.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okamoto, K | 1 |
| Isomoto, H | 1 |
| Shikuwa, S | 1 |
| Nishiyama, H | 1 |
| Ito, M | 1 |
| Kohno, S | 1 |
| Nishiyama, M | 1 |
| Maeda, K | 1 |
| Aoyagi, K | 1 |
| Sakisaka, S | 1 |
1 review available for lansoprazole and Cronkhite-Canada Syndrome
| Article | Year |
|---|---|
[Cap polyposis and Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Cla | 2005 |
1 other study available for lansoprazole and Cronkhite-Canada Syndrome
| Article | Year |
|---|---|
A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Alopecia; Amoxicillin; Anti-Bacterial Agents; Anti-Ul | 2008 |